ContraFect Corporation (CFRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 21, 2026
ContraFect Market Cap
ContraFect has a market cap or net worth of $1.07 thousand as of September 4, 2026. Its market cap has decreased by -80.01% in one year.
Market Cap
1.07K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since September 15, 2014, ContraFect's market cap has decreased from 87.34M to 1.07K, a decrease of -100.00%. That is a compound annual growth rate of -61.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.07K | 900.00% |
| Dec 30, 2025 | 107.00 | 872.73% |
| Dec 26, 2024 | 11.00 | -100.00% |
| Dec 29, 2023 | 321.14K | -92.34% |
| Dec 30, 2022 | 4.19M | -95.95% |
| Dec 31, 2021 | 103.45M | -26.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RegeneRx Biopharmaceuticals | 1.66K |
| Affimed | 1.64K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| Trevena | 959.00 |
| American Oriental Bioengineering | 949.00 |